Resistance Patterns Associated with HCV NS5A Inhibitors Provide Limited Insight into Drug Binding
出版年份 2014 全文链接
标题
Resistance Patterns Associated with HCV NS5A Inhibitors Provide Limited Insight into Drug Binding
作者
关键词
-
出版物
Viruses-Basel
Volume 6, Issue 11, Pages 4227-4241
出版商
MDPI AG
发表日期
2014-11-07
DOI
10.3390/v6114227
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Burden of Disease and Cost of Chronic Hepatitis C Virus Infection in Canada
- (2016) Robert P Myers et al. Canadian Journal of Gastroenterology and Hepatology
- The Combination of Alisporivir plus an NS5A Inhibitor Provides Additive to Synergistic Anti-Hepatitis C Virus Activity without Detectable Cross-Resistance
- (2014) Udayan Chatterji et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Comparison of Daclatasvir Resistance Barriers on NS5A from Hepatitis C Virus Genotypes 1 to 6: Implications for Cross-Genotype Activity
- (2014) Chunfu Wang et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Targeting the NS5A protein of HCV: An emerging option
- (2014) D.G. Cordek et al. DRUGS OF THE FUTURE
- Daclatasvir-Like Inhibitors of NS5A Block Early Biogenesis of Hepatitis C Virus–Induced Membranous Replication Factories, Independent of RNA Replication
- (2014) Carola Berger et al. GASTROENTEROLOGY
- Kinetic Analyses Reveal Potent and Early Blockade of Hepatitis C Virus Assembly by NS5A Inhibitors
- (2014) David R. McGivern et al. GASTROENTEROLOGY
- Simeprevir (TMC435) once daily with peginterferon-α-2b and ribavirin in patients with genotype 1 hepatitis C virus infection: The CONCERTO-4 study
- (2014) Hiromitsu Kumada et al. HEPATOLOGY RESEARCH
- Expanding the Proteome of an RNA Virus by Phosphorylation of an Intrinsically Disordered Viral Protein
- (2014) Daniel G. Cordek et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- A Refined Model of the HCV NS5A Protein Bound to Daclatasvir Explains Drug-Resistant Mutations and Activity against Divergent Genotypes
- (2014) Khaled H. Barakat et al. Journal of Chemical Information and Modeling
- Ledipasvir and Sofosbuvir for Untreated HCV Genotype 1 Infection
- (2014) Nezam Afdhal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Daclatasvir plus Sofosbuvir for Previously Treated or Untreated Chronic HCV Infection
- (2014) Mark S. Sulkowski et al. NEW ENGLAND JOURNAL OF MEDICINE
- The crystal structure of NS5A domain 1 from genotype 1a reveals new clues to the mechanism of action for dimeric HCV inhibitors
- (2014) Sebastian M. Lambert et al. PROTEIN SCIENCE
- Potent hepatitis C inhibitors bind directly to NS5A and reduce its affinity for RNA
- (2014) David B. Ascher et al. Scientific Reports
- Hepatitis C NS5A protein: two drug targets within the same protein with different mechanisms of resistance
- (2014) Precious J Lim et al. Current Opinion in Virology
- A Quantitative High-Resolution Genetic Profile Rapidly Identifies Sequence Determinants of Hepatitis C Viral Fitness and Drug Sensitivity
- (2014) Hangfei Qi et al. PLoS Pathogens
- Persistence of Resistant Variants in Hepatitis C Virus-Infected Patients Treated with the NS5A Replication Complex Inhibitor Daclatasvir
- (2013) Chunfu Wang et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Discovery of MK-8742: An HCV NS5A Inhibitor with Broad Genotype Activity
- (2013) Craig A. Coburn et al. ChemMedChem
- Efficacy of an Interferon- and Ribavirin-Free Regimen of Daclatasvir, Asunaprevir, and BMS-791325 in Treatment-Naive Patients With HCV Genotype 1 Infection
- (2013) Gregory T. Everson et al. GASTROENTEROLOGY
- Nucleotide Polymerase Inhibitor Sofosbuvir plus Ribavirin for Hepatitis C
- (2013) Edward J. Gane et al. NEW ENGLAND JOURNAL OF MEDICINE
- Modeling shows that the NS5A inhibitor daclatasvir has two modes of action and yields a shorter estimate of the hepatitis C virus half-life
- (2013) J. Guedj et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Characterizations of HCV NS5A replication complex inhibitors
- (2013) Donald R. O'Boyle II et al. VIROLOGY
- Profile of alisporivir and its potential in the treatment of hepatitis C
- (2013) Philippe Gallay et al. Drug Design Development and Therapy
- The Lipid Kinase Phosphatidylinositol-4 Kinase III Alpha Regulates the Phosphorylation Status of Hepatitis C Virus NS5A
- (2013) Simon Reiss et al. PLoS Pathogens
- In VitroActivity of Daclatasvir on Hepatitis C Virus Genotype 3 NS5A
- (2012) Chunfu Wang et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Boceprevir
- (2012) Karly P. Garnock-Jones DRUGS
- Telaprevir
- (2012) Caroline M. Perry DRUGS
- Hepatitis C Virus NS5B and Host Cyclophilin A Share a Common Binding Site on NS5A
- (2012) Claire Rosnoblet et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Understanding triphasic HCV decline during treatment in the era of IL28B polymorphisms and direct acting antiviral agents via mathematical modeling
- (2012) Harel Dahari et al. JOURNAL OF HEPATOLOGY
- The distinct contributions of fitness and genetic barrier to the development of antiviral drug resistance
- (2012) Matthias Götte Current Opinion in Virology
- In VitroActivity of BMS-790052 on Hepatitis C Virus Genotype 4 NS5A
- (2011) Chunfu Wang et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Genotypic and phenotypic analysis of variants resistant to hepatitis C virus nonstructural protein 5A replication complex inhibitor BMS-790052 in Humans: In Vitro and In Vivo Correlations
- (2011) Robert A. Fridell et al. HEPATOLOGY
- The effects of NS5A inhibitors on NS5A phosphorylation, polyprotein processing and localization
- (2011) D. Qiu et al. JOURNAL OF GENERAL VIROLOGY
- Distinct Functions of NS5A in Hepatitis C Virus RNA Replication Uncovered by Studies with the NS5A Inhibitor BMS-790052
- (2011) R. A. Fridell et al. JOURNAL OF VIROLOGY
- Contribution of a mutational bias in hepatitis C virus replication to the genetic barrier in the development of drug resistance
- (2011) M. H. Powdrill et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Resistance Analysis of the Hepatitis C Virus NS5A Inhibitor BMS-790052 in an In Vitro Replicon System
- (2010) R. A. Fridell et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- IL28B polymorphisms and chronic hepatitis C
- (2010) S. Chevaliez et al. GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE
- Recombinant HCV Variants With NS5A From Genotypes 1–7 Have Different Sensitivities to an NS5A Inhibitor but Not Interferon-α
- (2010) Troels K.H. Scheel et al. GASTROENTEROLOGY
- Hepatitis C Virus Nonstructural Protein 5A: Biochemical Characterization of a Novel Structural Class of RNA-Binding Proteins
- (2010) J. Hwang et al. JOURNAL OF VIROLOGY
- Chemical genetics strategy identifies an HCV NS5A inhibitor with a potent clinical effect
- (2010) Min Gao et al. NATURE
- DEB025 (Alisporivir) Inhibits Hepatitis C Virus Replication by Preventing a Cyclophilin A Induced Cis-Trans Isomerisation in Domain II of NS5A
- (2010) Lotte Coelmont et al. PLoS One
- The Domain 2 of the HCV NS5A Protein Is Intrinsically Unstructured
- (2010) Xavier Hanoulle et al. PROTEIN AND PEPTIDE LETTERS
- Domain 3 of non-structural protein 5A from hepatitis C virus is natively unfolded
- (2009) Xavier Hanoulle et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Identification of Hepatitis C Virus NS5A Inhibitors
- (2009) J. A. Lemm et al. JOURNAL OF VIROLOGY
- Crystal Structure of a Novel Dimeric Form of NS5A Domain I Protein from Hepatitis C Virus
- (2009) R. A. Love et al. JOURNAL OF VIROLOGY
- Pegylated interferon-α-based treatment for chronic hepatitis C in renal transplant recipients: an open pilot study
- (2009) Georges-Philippe Pageaux et al. TRANSPLANT INTERNATIONAL
- Hepatitis C virus infection protein network
- (2008) B de Chassey et al. Molecular Systems Biology
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now